NCT07306221 Effect of Visual-Guided Balance Training on Knee Motor Function and Biomechanical Characteristics After ACL Reconstruction
| NCT ID | NCT07306221 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Anterior Cruciate Ligament Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2025-11-22 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2025-11-22 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the improvement effect of visual-guided balance training on the knee joint function and gait performance of patients after ACLR, and to clarify the advantages of this training program compared to conventional rehabilitation training; at the same time, by including healthy individuals as the control group, it quantifies the differences in knee joint function and gait performance between patients after ACLR and healthy individuals, to verify whether visual-guided balance training can more effectively narrow the functional gap between patients after ACLR and healthy individuals, and promote the recovery of patients' knee joint function and gait closer to the healthy level. Ultimately, it provides scientific theoretical basis and practical guidance for the optimization of the rehabilitation plan after ACLR, and helps patients achieve comprehensive and high-quality recovery.
Eligibility Criteria
Inclusion criteria for patients: 1. Age between 18 and 45 years old; 2. Body Mass Index (BMI) ranging from 18.5 kg/m² to less than 35 kg/m²; 3. First unilateral ACL rupture and reconstruction surgery performed at this hospital; 4. Autologous hamstring tendon transplantation; 5. No or only minor injury to the meniscus, posterior cruciate ligament, medial collateral ligament or lateral collateral ligament; 6. Voluntary participation in this study and signing of informed consent form. Exclusion criteria for patients: 1. Patients who underwent ACL reconstruction more than one year after the injury; 2. Patients with severe injuries to the posterior cruciate ligament, medial collateral ligament or lateral collateral ligament (more than grade I; grade II is partial tear, thickening and tortuosity of the ligament, partial fiber interruption, and swelling of the surrounding soft tissues; grade III is complete rupture). ； Combined with severe meniscus tear; 3. Has a history of previous knee surgery, such as meniscus repair, ligament reconstruction, joint replacement, joint cleaning, etc.; 4. Has other knee joint diseases, such as: knee osteoarthritis, knee joint tumor, rheumatoid arthritis, tuberculosis, knee joint infection or inflammatory diseases, fracture, dislocation or other bone injuries, etc.; 5. Severe heart, lung, brain diseases or liver and kidney dysfunction, and visual and cognitive impairments. Inclusion criteria for the healthy control group 1. Age 18-45 years old; 2. Body Mass Index (BMI) ≥ 18.5 kg/m2 and \< 35 kg/m2; 3. No surgical history, injury history, or chronic joint diseases of the lower extremities; 4. No visual, cognitive impairments or neurological diseases; 5. No trauma or diseases that cause abnormal gait. Exclusion criteria 1\. Poor compliance of the subject; 2. The subject withdraws the informed consent form; 3.The subject requests to terminate the study or is unable to complete all the trials for some reason; 4. The investigator believes that the subject's continued participation in the trial may cause significant adverse effects on their physical condition; 5. The ethics review committee decides to terminate the trial.
Contact & Investigator
ren shuang, doctor
STUDY CHAIR
Be affiliated with the organization
Frequently Asked Questions
Who can join the NCT07306221 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Anterior Cruciate Ligament Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07306221 currently recruiting?
Yes, NCT07306221 is actively recruiting participants. Contact the research team at xixishuang123@126.com for enrollment information.
Where is the NCT07306221 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07306221 clinical trial?
NCT07306221 is sponsored by Peking University Third Hospital. The principal investigator is ren shuang, doctor at Be affiliated with the organization. The trial plans to enroll 45 participants.